About PCI domain-containing protein 2
PCI domain-containing protein 2 (PCID2) is a protein
from Homo sapiens identified by UniProt accession
Q5JVF3, 399 residues long.
MolForge cross-references it against 0 known binders and
31 disease associations.
Target properties
| Protein name | PCI domain-containing protein 2 |
| UniProt accession | Q5JVF3 |
| Gene | PCID2 |
| Organism | Homo sapiens |
| Length | 399 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (31)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.46
- mean corpuscular volume · score 0.29
- protein measurement · score 0.25
- blood protein measurement · score 0.23
- mean corpuscular hemoglobin · score 0.22
- mean corpuscular hemoglobin concentration · score 0.21
- dual specificity mitogen-activated protein kinase kinase 2 measurement · score 0.18
- Red cell distribution width · score 0.15
- reticulocyte measurement · score 0.12
- body height · score 0.10
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q5JVF3-F1 | alphafold | PREDICTED | 95.54 | — |
Amino-acid sequence (399 residues)
MAHITINQYL QQVYEAIDSR DGASCAELVS FKHPHVANPR LQMASPEEKC QQVLEPPYDE MFAAHLRCTY AVGNHDFIEA YKCQTVIVQS FLRAFQAHKE ENWALPVMYA VALDLRVFAN NADQQLVKKG KSKVGDMLEK AAELLMSCFR VCASDTRAGI EDSKKWGMLF LVNQLFKIYF KINKLHLCKP LIRAIDSSNL KDDYSTAQRV TYKYYVGRKA MFDSDFKQAE EYLSFAFEHC HRSSQKNKRM ILIYLLPVKM LLGHMPTVEL LKKYHLMQFA EVTRAVSEGN LLLLHEALAK HEAFFIRCGI FLILEKLKII TYRNLFKKVY LLLKTHQLSL DAFLVALKFM QVEDVDIDEV QCILANLIYM GHVKGYISHQ HQKLVVSKQN PFPPLSTVC
Explore PCI domain-containing protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets